Search research articles
Contact Us
Filters
Showing results (111-120 of 308) with videos related to
Page
of 31
Sort By:
Cancer Journal (Sudbury, Mass.)
|
June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones
S R Riddell, E H Warren, M A Gavin, et al.
Brain Research. Molecular Brain Research
|
September 5, 2001
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation
S Bates, S J Read, D C Harrison, et al.
Blood
|
February 3, 2009
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
Stefan Knop, Christian Gerecke, Peter Liebisch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 20, 2019
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Anthony S Stein, Hagop Kantarjian, Nicola Gökbuget, et al.
Cancer
|
November 3, 2020
Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Nicola Gökbuget, Gerhard Zugmaier, et al.
Cancer Research
|
November 17, 2006
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M Kowolik, Max S Topp, Sergio Gonzalez, et al.
Journal of the American College of Surgeons
|
June 8, 1999
Systemic effects and side effects of interstitial techniques used in liver tissue
C Brunken, S Topp, C Tesch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Blood Cancer Journal
|
July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Maximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Blood Cancer Journal
|
November 1, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Maximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 308) with videos related to
Sort By:
Page
of 31
Cancer Journal (Sudbury, Mass.)
|
June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones
S R Riddell, E H Warren, M A Gavin, et al.
Brain Research. Molecular Brain Research
|
September 5, 2001
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation
S Bates, S J Read, D C Harrison, et al.
Blood
|
February 3, 2009
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
Stefan Knop, Christian Gerecke, Peter Liebisch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 20, 2019
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Anthony S Stein, Hagop Kantarjian, Nicola Gökbuget, et al.
Cancer
|
November 3, 2020
Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S Topp, Nicola Gökbuget, Gerhard Zugmaier, et al.
Cancer Research
|
November 17, 2006
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M Kowolik, Max S Topp, Sergio Gonzalez, et al.
Journal of the American College of Surgeons
|
June 8, 1999
Systemic effects and side effects of interstitial techniques used in liver tissue
C Brunken, S Topp, C Tesch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Blood Cancer Journal
|
July 30, 2025
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Maximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Blood Cancer Journal
|
November 1, 2025
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
Maximilian J Steinhardt, Christoph Schaefers, Lisa B Leypoldt, et al.
Page
of 31